Cargando…
Determinants of HIV-1 Late Presentation in Patients Followed in Europe
To control the Human Immunodeficiency Virus (HIV) pandemic, the World Health Organization (WHO) set the 90-90-90 target to be reached by 2020. One major threat to those goals is late presentation, which is defined as an individual presenting a TCD4+ count lower than 350 cells/mm(3) or an AIDS-defini...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308660/ https://www.ncbi.nlm.nih.gov/pubmed/34357985 http://dx.doi.org/10.3390/pathogens10070835 |
_version_ | 1783728334075592704 |
---|---|
author | Miranda, Mafalda N. S. Pingarilho, Marta Pimentel, Victor Martins, Maria do Rosário O. Vandamme, Anne-Mieke Bobkova, Marina Böhm, Michael Seguin-Devaux, Carole Paredes, Roger Rubio, Rafael Zazzi, Maurizio Incardona, Francesca Abecasis, Ana |
author_facet | Miranda, Mafalda N. S. Pingarilho, Marta Pimentel, Victor Martins, Maria do Rosário O. Vandamme, Anne-Mieke Bobkova, Marina Böhm, Michael Seguin-Devaux, Carole Paredes, Roger Rubio, Rafael Zazzi, Maurizio Incardona, Francesca Abecasis, Ana |
author_sort | Miranda, Mafalda N. S. |
collection | PubMed |
description | To control the Human Immunodeficiency Virus (HIV) pandemic, the World Health Organization (WHO) set the 90-90-90 target to be reached by 2020. One major threat to those goals is late presentation, which is defined as an individual presenting a TCD4+ count lower than 350 cells/mm(3) or an AIDS-defining event. The present study aims to identify determinants of late presentation in Europe based on the EuResist database with HIV-1 infected patients followed-up between 1981 and 2019. Our study includes clinical and socio-demographic information from 89851 HIV-1 infected patients. Statistical analysis was performed using RStudio and SPSS and a Bayesian network was constructed with the WEKA software to analyze the association between all variables. Among 89,851 HIV-1 infected patients included in the analysis, the median age was 33 (IQR: 27.0–41.0) years and 74.4% were males. Of those, 28,889 patients (50.4%) were late presenters. Older patients (>56), heterosexuals, patients originated from Africa and patients presenting with log VL >4.1 had a higher probability of being late presenters (p < 0.001). Bayesian networks indicated VL, mode of transmission, age and recentness of infection as variables that were directly associated with LP. This study highlights the major determinants associated with late presentation in Europe. This study helps to direct prevention measures for this population. |
format | Online Article Text |
id | pubmed-8308660 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-83086602021-07-25 Determinants of HIV-1 Late Presentation in Patients Followed in Europe Miranda, Mafalda N. S. Pingarilho, Marta Pimentel, Victor Martins, Maria do Rosário O. Vandamme, Anne-Mieke Bobkova, Marina Böhm, Michael Seguin-Devaux, Carole Paredes, Roger Rubio, Rafael Zazzi, Maurizio Incardona, Francesca Abecasis, Ana Pathogens Article To control the Human Immunodeficiency Virus (HIV) pandemic, the World Health Organization (WHO) set the 90-90-90 target to be reached by 2020. One major threat to those goals is late presentation, which is defined as an individual presenting a TCD4+ count lower than 350 cells/mm(3) or an AIDS-defining event. The present study aims to identify determinants of late presentation in Europe based on the EuResist database with HIV-1 infected patients followed-up between 1981 and 2019. Our study includes clinical and socio-demographic information from 89851 HIV-1 infected patients. Statistical analysis was performed using RStudio and SPSS and a Bayesian network was constructed with the WEKA software to analyze the association between all variables. Among 89,851 HIV-1 infected patients included in the analysis, the median age was 33 (IQR: 27.0–41.0) years and 74.4% were males. Of those, 28,889 patients (50.4%) were late presenters. Older patients (>56), heterosexuals, patients originated from Africa and patients presenting with log VL >4.1 had a higher probability of being late presenters (p < 0.001). Bayesian networks indicated VL, mode of transmission, age and recentness of infection as variables that were directly associated with LP. This study highlights the major determinants associated with late presentation in Europe. This study helps to direct prevention measures for this population. MDPI 2021-07-02 /pmc/articles/PMC8308660/ /pubmed/34357985 http://dx.doi.org/10.3390/pathogens10070835 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Miranda, Mafalda N. S. Pingarilho, Marta Pimentel, Victor Martins, Maria do Rosário O. Vandamme, Anne-Mieke Bobkova, Marina Böhm, Michael Seguin-Devaux, Carole Paredes, Roger Rubio, Rafael Zazzi, Maurizio Incardona, Francesca Abecasis, Ana Determinants of HIV-1 Late Presentation in Patients Followed in Europe |
title | Determinants of HIV-1 Late Presentation in Patients Followed in Europe |
title_full | Determinants of HIV-1 Late Presentation in Patients Followed in Europe |
title_fullStr | Determinants of HIV-1 Late Presentation in Patients Followed in Europe |
title_full_unstemmed | Determinants of HIV-1 Late Presentation in Patients Followed in Europe |
title_short | Determinants of HIV-1 Late Presentation in Patients Followed in Europe |
title_sort | determinants of hiv-1 late presentation in patients followed in europe |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308660/ https://www.ncbi.nlm.nih.gov/pubmed/34357985 http://dx.doi.org/10.3390/pathogens10070835 |
work_keys_str_mv | AT mirandamafaldans determinantsofhiv1latepresentationinpatientsfollowedineurope AT pingarilhomarta determinantsofhiv1latepresentationinpatientsfollowedineurope AT pimentelvictor determinantsofhiv1latepresentationinpatientsfollowedineurope AT martinsmariadorosarioo determinantsofhiv1latepresentationinpatientsfollowedineurope AT vandammeannemieke determinantsofhiv1latepresentationinpatientsfollowedineurope AT bobkovamarina determinantsofhiv1latepresentationinpatientsfollowedineurope AT bohmmichael determinantsofhiv1latepresentationinpatientsfollowedineurope AT seguindevauxcarole determinantsofhiv1latepresentationinpatientsfollowedineurope AT paredesroger determinantsofhiv1latepresentationinpatientsfollowedineurope AT rubiorafael determinantsofhiv1latepresentationinpatientsfollowedineurope AT zazzimaurizio determinantsofhiv1latepresentationinpatientsfollowedineurope AT incardonafrancesca determinantsofhiv1latepresentationinpatientsfollowedineurope AT abecasisana determinantsofhiv1latepresentationinpatientsfollowedineurope |